A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Jiangsu HengRui Medicine Co., Ltd.
Revolution Medicines, Inc.
University of Turin, Italy
University Hospital Tuebingen
Shanghai Gebaide Biotechnology Co., Ltd.
Wuxi No. 4 People's Hospital
RWTH Aachen University
University Hospital, Angers